Israeli-based behavioral biometrics company BioCatch has announced that it has been named to the CB Insights Fintech 250, recognizing it as one of the fastest growing companies working to innovatively transform the fintech industry. Read...
Read MoreShivani Siroya knew that her startup Tala was going to be a success when an early customer told her, “This is the Kenya we want.” Over the past 9 years since the company was founded, it has served 4 million customers and raised $200 million in external capital. Its website is full of customer testimonials. “Tala told me to always dream big and I’m dreaming it. Very soon, I’ll call for [a] celebration when we are opening our bakery because I believe with Tala, I’m going far,” said pastry chef Baraka Vola in a testimonial video. Read more...
Read MoreVaro Bank, which became the first U.S. fintech to earn a national banking license when the Office of the Comptroller of the Currency (OCC) awarded it a charter last month, will soon move operations to the Temenos cloud banking platform. It received its FDIC approval for deposit insurance in February. Read...
Read MoreDailyPay, the gold standard of the on-demand pay ecosystem, today announced that Chief Executive Officer, Jason Lee, has been named the Gold Winner for Innovator of the Year for this year’s CEO World Awards. Read...
Read MoreThe health industry has increasingly emphasized convenience these past few decades, with methods developed to seamlessly integrate health management into our daily routines. Gone are the days in which people needed an entire day off just to see the doctor. This same focus has taken on extra meaning as of late, with the pandemic creating a need for treatment options that work around the constraints of social distancing. As a result, a host of digital-based solutions began appearing, providing remote solutions for people’s medical requirements, particularly diabetes patients who need regular appointments with their doctors. But one question remains: Will these services retain their appeal once we’ve returned to our “new normal?” Read...
Read More
